The discovery of the rare natural amyloidogenic variant of β2-m allowed a systematic analysis of its pathological and biochemical features as well as providing the opportunity to correlate specific molecular characteristics of the WT and of the variant with peculiar clinical presentations and different pathological features of the two related types of amyloidosis. The gene discussed is B2M; the disease is amyloidosis.